Ken‐Ichiro Yoshida

3.0k total citations
118 papers, 2.4k citations indexed

About

Ken‐Ichiro Yoshida is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ken‐Ichiro Yoshida has authored 118 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 37 papers in Pulmonary and Respiratory Medicine and 33 papers in Oncology. Recurrent topics in Ken‐Ichiro Yoshida's work include Renal cell carcinoma treatment (18 papers), Hormonal and reproductive studies (17 papers) and Urinary Bladder and Prostate Research (13 papers). Ken‐Ichiro Yoshida is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Hormonal and reproductive studies (17 papers) and Urinary Bladder and Prostate Research (13 papers). Ken‐Ichiro Yoshida collaborates with scholars based in Japan, United States and United Kingdom. Ken‐Ichiro Yoshida's co-authors include Takao Kamai, Tomonori Yamanishi, Hideyuki Abe, Kyoko Arai, Hiromichi Shirataki, Mikihiko Honda, Satoshi Kitahara, Yoshitatsu Fukabori, Shuhei Sumi and Tomoya Mizuno and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Ken‐Ichiro Yoshida

115 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken‐Ichiro Yoshida Japan	28	924	769	593	333	302	118	2.4k
Yoshitatsu Fukabori Japan	23	1.0k 1.1×	971 1.3×	328 0.6×	255 0.8×	162 0.5×	89	2.3k
Funda Vakar‐Lopez United States	25	905 1.0×	1.0k 1.3×	490 0.8×	116 0.3×	410 1.4×	59	2.2k
Francis Vacherot France	29	1.1k 1.2×	1.2k 1.6×	349 0.6×	302 0.9×	138 0.5×	73	2.5k
Alexander Kirschenbaum United States	30	1.3k 1.4×	749 1.0×	549 0.9×	188 0.6×	214 0.7×	62	3.2k
Ralph Buttyan United States	37	1.6k 1.7×	1.3k 1.6×	612 1.0×	633 1.9×	336 1.1×	86	3.5k
Roberta Mazzucchelli Italy	30	1.1k 1.2×	1.2k 1.6×	521 0.9×	192 0.6×	800 2.6×	145	2.9k
Francisco G. La Rosa United States	23	541 0.6×	747 1.0×	244 0.4×	103 0.3×	491 1.6×	88	2.2k
Aud Svindland Norway	32	928 1.0×	1.3k 1.7×	618 1.0×	84 0.3×	526 1.7×	84	3.1k
Dov Kadmon United States	39	1.5k 1.6×	2.1k 2.8×	873 1.5×	446 1.3×	715 2.4×	126	4.5k
Iris E. Eder Austria	29	1.4k 1.5×	1.5k 1.9×	623 1.1×	125 0.4×	237 0.8×	72	3.0k

Countries citing papers authored by Ken‐Ichiro Yoshida

Since Specialization

Citations

This map shows the geographic impact of Ken‐Ichiro Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐Ichiro Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐Ichiro Yoshida more than expected).

Fields of papers citing papers by Ken‐Ichiro Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐Ichiro Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐Ichiro Yoshida. The network helps show where Ken‐Ichiro Yoshida may publish in the future.

Co-authorship network of co-authors of Ken‐Ichiro Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐Ichiro Yoshida. A scholar is included among the top collaborators of Ken‐Ichiro Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐Ichiro Yoshida. Ken‐Ichiro Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamai, Takao, Toshiki Kijima, Toyonori Tsuzuki, et al.. (2021). Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival. Cancer Immunology Immunotherapy. 70(7). 2009–2021. 33 indexed citations

Nukui, Akinori, Takahiro Narimatsu, Hideyuki Abe, et al.. (2018). Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer. BMC Cancer. 18(1). 493–493. 5 indexed citations

Betsunoh, Hironori, Naohiko Anzai, Tomoya Mizuno, et al.. (2013). Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. BMC Cancer. 13(1). 509–509. 65 indexed citations

Kamai, Takao, Hiromichi Shirataki, Yoshiaki Yanai, et al.. (2011). Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma. Cancer Immunology Immunotherapy. 60(6). 793–808. 16 indexed citations

Yamada, Shizuo, et al.. (2010). The N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and Pharmacokinetics. Drug Metabolism and Disposition. 38(8). 1314–1321. 15 indexed citations

Yamanishi, Tomonori, et al.. (2009). Urodynamic effects of silodosin, a new α_1A‐adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia. Neurourology and Urodynamics. 29(4). 558–562. 49 indexed citations

Masuda, Akinori, Takao Kamai, Hideyuki Abe, Kyoko Arai, & Ken‐Ichiro Yoshida. (2009). Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?. Biomedical Research. 30(3). 171–176. 18 indexed citations

Abe, Hideyuki, Takao Kamai, Hiromichi Shirataki, et al.. (2008). High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. International Journal of Cancer. 122(10). 2391–2397. 58 indexed citations

Uchida, Shinya, et al.. (2007). Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain. Life Sciences. 80(26). 2454–2460. 17 indexed citations

10.

Koga, Fumitaka, Satoshi Kitahara, Kyoko Arai, et al.. (2000). Negative p53/Positive p21 Immunostaining Is a Predictor of Favorable Response to Chemotherapy in Patients with Locally Advanced Bladder Cancer. Japanese Journal of Cancer Research. 91(4). 416–423. 17 indexed citations

11.

Koga, Fumitaka, et al.. (2000). Sarcomatoid renal cell carcinoma with scant carcinomatous components. International Journal of Urology. 7(2). 58–60. 8 indexed citations

12.

Sumi, Shuhei, et al.. (1999). Serial lectin affinity chromatography demonstrates altered asparagine-linked sugar-chain structures of prostate-specific antigen in human prostate carcinoma. Journal of Chromatography B Biomedical Sciences and Applications. 727(1-2). 9–14. 47 indexed citations

13.

Yoshida, Ken‐Ichiro, et al.. (1999). Alterations of asparagine-linked sugar chains of N-acetyl β-d-hexosaminidase during human renal oncogenesis: a preliminary study using serial lectin affinity chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 723(1-2). 75–80. 11 indexed citations

14.

Koga, Fumitaka, Toyohiko Satoh, Hideo Sasaki, et al.. (1998). Voided urine cytology in urothelial cancer of the upper urinary tract - Correlation between histopathologic and cytologic findings, and relationship between exfoliation of neoplastic cells and renal function.. The Journal of the Japanese Society of Clinical Cytology. 37(3). 279–285.

15.

Arai, Kyoko, et al.. (1997). Serum Levels of the Carboxy-TervninalPropeptide of Type I Procollagen andthe Pyridinoline Cross-LinkedCarboxy-Terminal Telopeptide ofType I Collagen as Markers of BoneMetastases in Patients withProstate Carcinoma. European Urology. 31(2). 220–223. 7 indexed citations

16.

Yoshida, Ken‐Ichiro, et al.. (1997). Studies of the Expression of Epidermal Growth Factor Receptor in Human Renal Cell Carcinoma: A Comparison of Immunohistochemical Method versus Ligand Binding Assay. Oncology. 54(3). 220–225. 11 indexed citations

17.

Yoshida, Ken‐Ichiro & Akira Tosaka. (1994). EPIDERMAL GROWTH FACTOR BINDING BY MEMBRANES OF HUMAN RENAL CELL CARCINOMAS: ESTABLISHMENT OF AN EPIDERMAL GROWTH FACTOR RECEPTOR ASSAY FOR CLINICAL USE. International Journal of Urology. 1(4). 319–323. 6 indexed citations

18.

Yoshida, Ken‐Ichiro. (1993). STUDY ON THE ENZYMATIC PROPERTIES OF N-ACETYL-^|^beta;, D-GLUCOSAMINIDASE A (NAG A) FROM THE TISSUE OF RENAL CELL CARCINOMAS. The Japanese Journal of Urology. 84(11). 2008–2014. 1 indexed citations

19.

Yoshida, Ken‐Ichiro, et al.. (1989). SEPARATION AND PROPERTIES OF N-ACETYL^|^beta;-D-GLUCOSAMINIDASE FROM HUMAN SEMINAL PLASMA. The Japanese Journal of Urology. 80(11). 1625–1631. 2 indexed citations

20.

Marunaka, Teruyoshi, et al.. (1988). High-performance liquid chromatographic determination of 6-amidino-2-naphthyl [4-(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulphonate and its metabolites in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 433. 177–186. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact